Mirae Asset Global ETFs Holdings
HRMY icon

Mirae Asset Global ETFs Holdings’s Harmony Biosciences HRMY Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$757K Buy
20,804
+272
+1% +$8.58K ﹤0.01% 1780
2026
Q1 		$575K Buy
20,532
+258
+1% +$8.46K ﹤0.01% 1817
2025
Q4 		$759K Sell
20,274
-48
-0.2% -$1.58K ﹤0.01% 1674
2025
Q3 		$560K Sell
20,322
-3,649
-15% -$126K ﹤0.01% 1818
2025
Q2 		$757K Buy
23,971
+1,320
+6% +$42.5K ﹤0.01% 1586
2025
Q1 		$752K Buy
22,651
+984
+5% +$35.3K ﹤0.01% 1638
2024
Q4 		$746K Buy
21,667
+5,099
+31% +$175K ﹤0.01% 1707
2024
Q3 		$663K Buy
16,568
+298
+2% +$10.5K ﹤0.01% 1772
2024
Q2 		$491K Buy
+16,270
New +$489K ﹤0.01% 1838

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's HRMY Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Harmony Biosciences (HRMY) stake by 1.3% in Q2 2026, buying an estimated $8.58K and bringing the position to 20,804 shares worth $757K. The position accounts for ﹤0.01% of the portfolio, ranked #1780.

Mirae Asset Global ETFs Holdings first reported a position in HRMY in Q2 2024 and has held it in 9 quarters since. The position peaked at $759K in Q4 2025. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 20,804 shares of Harmony Biosciences worth $757K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings bought 272 Harmony Biosciences shares in Q2 2026, an estimated $8.58K.
  • Harmony Biosciences made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1780 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Harmony Biosciences in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global ETFs Holdings's Harmony Biosciences position peaked at $759K in Q4 2025.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.